Delving into the Latest Updates on The Fraunhofer Center for Molecular Biotechnology with Synapse

概览

关联

2

项与 The Fraunhofer Center for Molecular Biotechnology 相关的药物

Pfs25 malaria vaccine(Johns Hopkins Bloomberg School of Public Health)

靶点-

作用机制

免疫刺激剂

在研机构

Johns Hopkins Bloomberg School of Public Health

原研机构

Johns Hopkins Bloomberg School of Public Health

在研适应症

疟疾

非在研适应症-

最高研发阶段临床2期

首次获批国家/地区-

首次获批日期-

PA-83-FhCMB

靶点-

作用机制

免疫刺激剂

在研机构-

原研机构

iBio, Inc.

在研适应症-

非在研适应症

炭疽

最高研发阶段无进展

首次获批国家/地区-

首次获批日期-

4

项与 The Fraunhofer Center for Molecular Biotechnology 相关的临床试验

NCT02239172 / Completed临床1期

A Phase 1 Study of the Safety and Immunogenicity of Plant-Derived Recombinant Protective Antigen (rPA) Anthrax Vaccine in Healthy Adults

The purposes of this study is to evaluate and compare the safety, reactogenicity, and tolerability of the PA83-FhCMB vaccine candidate delivered at 4 dose levels with Alhydrogel

开始日期2014-08-01

申办/合作机构

The Fraunhofer Center for Molecular Biotechnology

NCT02013687 / Completed临床1期

A Phase 1 Study of the Safety and Immunogenicity of Plant-Derived Pfs25 VLP-FhCMB Malaria Transmission Blocking Vaccine in Healthy Adults

This study is a Phase 1, dose escalation, first-in-human study designed primarily to evaluate the safety of the purified plant-derived Pfs25 VLP combined with Alhydrogel adjuvant

开始日期2013-10-01

申办/合作机构

The Fraunhofer Center for Molecular Biotechnology

NCT01250795 / Completed临床1期

A Phase 1a/b, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Dose Escalation Study to Investigate the Safety, Reactogenicity, and Immunogenicity of FhCMB HAI-05, a Recombinant Hemagglutinin (rHA) Vaccine Derived From Influenza A/Indonesia/05/2005 (H5N1), in Healthy Adults 18 to 49 Years

The purpose of this study is to assess the safety, immunogenicity,and tolerability of a H5N1 Vaccine in healthy adults.

开始日期2010-11-01

申办/合作机构

The Fraunhofer Center for Molecular Biotechnology

100 项与 The Fraunhofer Center for Molecular Biotechnology 相关的临床结果

登录后查看更多信息

0 项与 The Fraunhofer Center for Molecular Biotechnology 相关的专利（医药）

登录后查看更多信息

1

项与 The Fraunhofer Center for Molecular Biotechnology 相关的文献（医药）

The role of molecular farming in industrial biocatalysis

作者: Marrs, Barry L.

Biocatalysis has proven itself to be a cost-effective basis for the production of polymer-grade monomers, but it has done so in spite of a most serious handicap: the high cost of industrial enzymes.Virtually all industrial enzymes are currently produced via fermentation, and the cost of manufacturing enzymes this way is seldom less than $10/lb.Many candidate processes cannot bear that cost for catalyst.Mol. Farming, which includes the production of industrial enzymes in field crops, offers a route for biocatalyst production that promises to drive the cost down by as much as 10X.I shall discuss two types of mol. farming, transient gene expression and transgenic crops, and the ways they might contribute to industrial biocatalysis.

100 项与 The Fraunhofer Center for Molecular Biotechnology 相关的药物交易

登录后查看更多信息

100 项与 The Fraunhofer Center for Molecular Biotechnology 相关的转化医学

登录后查看更多信息